NFKB1 and urinary bladder cancer: Finally, we immunohistochemically stained for AR, NF-κB, and p-NF-κB in our tissue microarrays (TMAs) consisting of muscle-invasive bladder cancer specimens from patients who subsequently received neoadjuvant GC therapy (Figure 8).